Thomas Louis Saeli Acquires 5,000 Shares of Ultralife Co. (NASDAQ:ULBI) Stock

Ultralife Co. (NASDAQ:ULBI) Director Thomas Louis Saeli purchased 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $5.44 per share, with a total value of $27,200.00. Following the completion of the purchase, the director now owns 85,000 shares in the company, valued at $462,400. This trade represents a 6.25% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.

Ultralife Stock Performance

Shares of Ultralife stock opened at $5.92 on Friday. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The stock’s fifty day moving average is $4.92 and its two-hundred day moving average is $6.62. Ultralife Co. has a 52 week low of $4.07 and a 52 week high of $12.40. The company has a market capitalization of $98.47 million, a PE ratio of 10.76 and a beta of 0.77.

Ultralife (NASDAQ:ULBI) last issued its earnings results on Friday, May 9th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.02). The company had revenue of $50.75 million for the quarter, compared to analysts’ expectations of $54.50 million. Ultralife had a net margin of 5.44% and a return on equity of 7.92%. During the same period in the prior year, the firm posted $0.21 earnings per share.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Ultralife from a “hold” rating to a “buy” rating in a research note on Monday.

Hedge Funds Weigh In On Ultralife

A number of institutional investors have recently modified their holdings of the stock. Jane Street Group LLC purchased a new position in shares of Ultralife during the third quarter valued at $166,000. Barclays PLC raised its holdings in Ultralife by 21.3% in the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock worth $121,000 after purchasing an additional 2,355 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Ultralife by 250.8% during the third quarter. JPMorgan Chase & Co. now owns 47,458 shares of the technology company’s stock valued at $429,000 after acquiring an additional 33,929 shares during the last quarter. Janney Montgomery Scott LLC boosted its position in shares of Ultralife by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 447,000 shares of the technology company’s stock worth $3,330,000 after purchasing an additional 3,850 shares in the last quarter. Finally, IFP Advisors Inc acquired a new position in shares of Ultralife during the fourth quarter valued at about $85,000. 30.68% of the stock is owned by hedge funds and other institutional investors.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.